Teva, Baxter Told To Pay $104M In Propofol Hepatitis Case
A Nevada jury this week awarded $104 million in damages to a colonoscopy patient who sued U.S. subsidiaries of Teva Pharmaceutical Industries Ltd. and Baxter International Inc. claiming he contracted hepatitis...To view the full article, register now.
Already a subscriber? Click here to view full article